Premeaux, Thomas

Publications

Sort by

Co-Author Network

selected publications

Decrypting biological hallmarks of aging in people with HIV. Current opinion in HIV and AIDS. 2023 Academic Article GET IT
Impact of ART intensification with CCR5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS (London, England). 2023 Academic Article GET IT
Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV. AIDS research and human retroviruses. 2023 Academic Article GET IT
Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states. Journal of neurovirology. 2023 Academic Article GET IT
Increased transmigration of intermediate monocytes associated with atherosclerotic burden in people with HIV on antiretroviral therapy. AIDS (London, England). 2023 Letter GET IT
Multiplex analysis of cytokines and chemokines in persons aging with or without HIV. bioRxiv : the preprint server for biology. 2023 Article GET IT
Brain volumetrics differ by Fiebig stage in acute HIV infection. AIDS (London, England). 2023 Academic Article GET IT
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice. AIDS (London, England). 2022 Academic Article GET IT
Times cited: 1
Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection. Frontiers in immunology. 2022 Academic Article GET IT
Times cited: 1
Mucosal-homing natural killer cells are associated with aging in persons living with HIV. Cell reports. Medicine. 2022 Academic Article GET IT
Times cited: 2
Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection. Psychosomatic medicine. 2022 Academic Article GET IT
Times cited: 2
Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Frontiers in immunology. 2022 Review GET IT
Times cited: 5
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy. Open forum infectious diseases. 2022 Academic Article GET IT
Times cited: 1
Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam. AIDS research and human retroviruses. 2022 Academic Article GET IT
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy. AIDS (London, England). 2021 Academic Article GET IT
Times cited: 2
Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research. mBio. 2021 Review GET IT
Times cited: 7
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID. Allergy. 2021 Academic Article GET IT
Times cited: 22
Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Co-infection. Frontiers in neurology. 2021 Academic Article GET IT
Times cited: 19
Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. Journal of leukocyte biology. 2021 Academic Article GET IT
Times cited: 55
Hiding in plain sight - platelets, the silent carriers of HIV-1. Platelets. 2020 Academic Article GET IT
Times cited: 2
Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide. Frontiers in public health. 2020 Academic Article GET IT
Times cited: 20
Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy. Frontiers in immunology. 2020 Academic Article GET IT
Times cited: 11
Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals. AIDS (London, England). 2020 Academic Article GET IT
Times cited: 18
Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection. Frontiers in immunology. 2019 Academic Article GET IT
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in oncology. 2019 Academic Article GET IT
Times cited: 11
Geriatric Syndromes in Older Adults Living with HIV and Cognitive Impairment. Journal of the American Geriatrics Society. 2019 Academic Article GET IT
Times cited: 19
Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 12
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling. Frontiers in immunology. 2019 Academic Article GET IT
Times cited: 26
Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. Journal of neurovirology. 2018 Academic Article GET IT
Times cited: 18
Role of Natural Killer Cells in HIV-Associated Malignancies. Frontiers in immunology. 2017 Review GET IT
Times cited: 42

more ...

less ...

Background

education and training

Ph.D., University of Hawaii 2020
B.B.A., University of Hawaii 2016

Contact

full name

Thomas Premeaux

primary email

tap4002@med.cornell.edu

VIVO Weill Cornell Medical College

Thomas Premeaux Instructor of Immunology and Infectious Diseases in Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email